Navigation Links
Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Date:1/9/2008

and Director, Clinical Investigation and Translational Research in the Department of Lymphoma/Myeloma, M.D. Anderson Cancer Center and a principal investigator for this trial. "There have been no new approved therapies in relapsed/refractory Hodgkin lymphoma for decades. As epigenetics is thought to play a role in lymphoma, this clinical study will help build an understanding of the role of HDAC inhibitors and demethylating agents in the treatment of non-Hodgkin and Hodgkin lymphoma."

Encouraging anti-tumor activity has been demonstrated in a Phase 2 clinical study of MGCD0103 as a single agent in the relapsed or refractory Hodgkin lymphoma patient population. Data from the ongoing study, presented at the American Society of Hematology (ASH) annual meeting last month, reported an objective complete and partial response (CR and PR) rate of 38 percent and a disease control rate of 43 percent in 21 evaluable patients in the 110mg cohort. Eighty-six percent of patients who had CT scans experienced a reduction in tumor size, with 57 percent experiencing a tumor reduction of greater than 30 percent. The two CR patients have a preliminary progression-free survival (PFS) of 14 and nine months at the time of analysis, and the range of PFS from the responder group is 56 to greater than 396 days. Adverse events associated with MGCD0103 administration of grade 3 or higher included pneumonia (15 percent), thrombocytopenia (12 percent) and fatigue (nine percent). Dose modification was effective in many of these patients.

About MGCD0103

MGCD0103 is an orally-administered, isotype-selective HDAC inhibitor. The compound is currently in one Phase 1 combination clinical trial with Taxotere(R) for solid tumors, two Phase 1/2 combination trials with Vidaza(R) for hematological malignancies and with Gemzar(R) for pancreatic cancer; and five Phase 2 clinical trials in hematological malignancies.

MGCD0103 has received orphan drug designation from the U.S. Food a
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
3. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
4. Pharmion and MethylGene Initiate Phase One Combination Clinical Trial with MGCD0103 and Taxotere(R) in Patients with Solid Tumors
5. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
6. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
7. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
8. InterMune Announces Start of Phase 1b Trial of ITMN-191
9. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
10. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
11. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Corporation (Nasdaq: KEQU ) today reported results ... Sales for the quarter were $30,534,000, as compared ... year. Net earnings for the quarter were $1,234,000, or ... of $1,587,000, or $0.61 per diluted share, in the ... and earnings in the first quarter last year were ...
(Date:8/26/2014)... 26, 2014 Reportlinker.com announces that ... in its catalogue: Japan Esophagoscopes ... http://www.reportlinker.com/p02280977/Japan-Esophagoscopes--Gastroscopes-Market-Outlook-to-2020.html ... 2020 Summary GlobalData,s new report, ... 2020", provides key market data on the ...
(Date:8/26/2014)... , Aug. 26, 2014 Biomedical Research ... has been named to the prestigious 2014 Inc. 500 ... honored to be included on this prestigious list and ... Chris Jacob , Biomedical Research Laboratories, CEO. "Today,s ... further serves to validate the hard work and talent ...
Breaking Medicine Technology:Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 3Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 4Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 5Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2
... WASHINGTON, Oct. ... United States $1.375 million to resolve False Claims Act allegations that ... sham durable medical equipment (DME) provider, the Justice Department announced today. ... provided the kickbacks and assistance and, in return, Harborside purchased its ...
... , WESTON, Fla., Oct. 8 American Scientific Resources Inc. ... reports for the periods ending December 31, 2007 and December ... www.Pinksheets.com . ... , is a leading provider of innovative next-generation, health, ...
Cached Medicine Technology:Harborside Healthcare to Pay U.S. $1.375 Million to Resolve Allegations of Kickbacks and Sham Durable Medical Services 2American Scientific Resources Inc. Discloses Audited Financials for 2007 and 2008 2
(Date:8/27/2014)... August 27, 2014 A recent University ... found that the dental community disagrees on the ... their patients. Analysis of dental advice suggested that some ... no one technique more popular than the rest. ... to brush and floss your teeth regularly,” said Dr. ...
(Date:8/27/2014)... Angeles, CA (PRWEB) August 27, 2014 ... Meetup event in collaboration with Diabetes Community Advocacy Foundation ... on October 24-25, 2014 at Embassy Suites LAX North. ... Social Media Meetup featuring DSMA Live”, an event which ... Friday evening, October 24th. , Interactive in many ways, ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 ... , is excited to introduce a variety of yoga ... That Matters Yoga and Holistic Health Center. , ... Flow classes from senior teacher, Coral Brown, YogaVibes subscribers ... practices that resonate and teachers that transform with All ...
(Date:8/27/2014)... Discover Leadership Training is the foremost expert ... their comprehensive leadership programs. As the Vice President of ... the realm of outcome-focused and benefit-driven choices. Barb Moses ... webinar series titled, “A Women’s Guide to Making Her ... two part webinar is titled, “My Current Story” which ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 AAPC ... business of healthcare, is pleased to announce the ... online recruitment resource specifically designed for the healthcare ... significant changes. To help address the primary challenges ... tighter budgets—AAPC launched CareerHealth.com . , ...
Breaking Medicine News(10 mins):Health News:Americans Confused About How to Brush Teeth 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 3Health News:YogaVibes Brings All That Matters Yoga Online 2Health News:YogaVibes Brings All That Matters Yoga Online 3Health News:Barb Moses, Vice President of Discover Leadership Training, Announces New Webinar Titled, “A Women’s Guide to Making Her Life Story a Bestseller” 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 3
... tumors, study found , WEDNESDAY, Feb. 10 (HealthDay News) -- ... spiritual thinking and feeling in patients, a finding that adds ... physical makeup of the mind, researchers say. , The findings, ... are based on research in patients who had surgery to ...
... 40 percent of women don,t know it is leading killer, ... public awareness campaigns, almost half of all American women still ... death in women, new research finds. , Even more concerning, ... emergency help if they were having heart attack symptoms, according ...
... , PUYALLUP, Wash. , Feb. 10 ... and the American Recovery and Reinvestment Act became household ... imaging and data management integration project with interoperability provider ... for MINW patients even after the completion of the ...
... with Inflammatory Bowel Disease (IBD) are known to be at high ... of their disease but now new research by scientists at The ... to hospital during flare-ups are also at risk. The two ... affect about one in every 250 people in the UK. The ...
... Annals of Surgical Oncology (ASO), the official journal ... additional society affiliation with the American Society of Breast ... ASO is a leading monthly publication that features original ... from all specialties. Dr. William Curtis, Executive Vice ...
... The NADA convention and ... , ... Auto dealers will be able to attend free workshops hosted by KPA and TK ... Convention and Expo 2010., , ,The free workshops will be in the NADA exhibit hall in ...
Cached Medicine News:Health News:Physical Changes in Brain Linked to Altered Spirituality 2Health News:Women's Heart Disease Awareness Still Lacking 2Health News:Women's Heart Disease Awareness Still Lacking 3Health News:Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements 2Health News:Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements 3Health News:Bowel disease link to blood clots 2Health News:Bowel disease link to blood clots 3Health News:Annals of Surgical Oncology adds new society affiliation 2Health News:KPA and TK Carsites offer HR, OSHA and Internet Marketing Workshops at the NADA Convention and Expo 2010 2
Ribbon malleable, general purpose retractor....
The Wire Cutters are designed to cut Kirschner wires up to 2.5 mm diameter easily and smoothly. They are particularly useful for external fixation applications. The Wire Cutters shear fixation wires ...
The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes....
... Pulse CDC Compact Cardiac Digital Camera is a ... open, patient-friendly gantry, and provides full sized fields ... into your clinic you need a flexible system ... Find out how the Pulse reduces the ...
Medicine Products: